An Arg1239His mutation of the CACNL1A3 gene in a Korean family with hypokalemic periodic paralysis
暂无分享,去创建一个
Y. Woo | Myeong-Kyu Kim | Ji Youn Kim | Y. Cho | Y. O. Kim | C. Kim | C. Yeo
[1] Wei-Ping Wu,et al. [R1239H mutation of CACNA1S gene in a Chinese family with hypokalaemic periodic paralysis]. , 2006, Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics.
[2] S. Cannon,et al. The primary periodic paralyses: diagnosis, pathogenesis and treatment. , 2006, Brain : a journal of neurology.
[3] Kyung-Yil Lee,et al. A Korean Family of Hypokalemic Periodic Paralysis with Mutation in a Voltage-gated Calcium Channel (R1239G) , 2005, Journal of Korean medical science.
[4] Timothy A. Miller,et al. Correlating phenotype and genotype in the periodic paralyses , 2004, Neurology.
[5] Byeong-Chae Kim,et al. Mutation screening in Korean hypokalemic periodic paralysis patients: a novel SCN4A Arg672Cys mutation , 2004, Neuromuscular Disorders.
[6] K. Nakashima,et al. Muscle weakness in a Japanese family of Arg1239His mutation hypokalemic periodic paralysis , 2001, Psychiatry and clinical neurosciences.
[7] F. Lehmann-Horn,et al. Hypokalaemic periodic paralysis type 2 caused by mutations at codon 672 in the muscle sodium channel gene SCN4A. , 2001, Brain : a journal of neurology.
[8] U. Kim,et al. Identification of mutations including de novo mutations in Korean patients with hypokalaemic periodic paralysis. , 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[9] P. Tonali,et al. Impairment of skeletal muscle adenosine triphosphate-sensitive K+ channels in patients with hypokalemic periodic paralysis. , 1999, The Journal of clinical investigation.
[10] C. Wadelius,et al. Identification of mutations in the CACNL1A3 gene in 13 families of Scandinavian origin having hypokalemic periodic paralysis and evidence of a founder effect in Danish families. , 1997, American journal of medical genetics.
[11] R. Griggs,et al. Genotype-phenotype correlations of DHP receptor α 1-subunit gene mutations causing hypokalemic periodic paralysis , 1997, Neuromuscular Disorders.
[12] M. Martínez‐Frías. Primary midline developmental field. I. Clinical and epidemiological characteristics. , 1995, American journal of medical genetics.
[13] R. Ophoff,et al. Hypokalemic periodic paralysis and the dihydropyridine receptor (CACNL1A3): genotype/phenotype correlations for two predominant mutations and evidence for the absence of a founder effect in 16 caucasian families. , 1995, American journal of human genetics.
[14] Hal B. Jenson,et al. Nelson Textbook of Pediatrics , 1965 .